Skip to main content
Log in

Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome

  • Original investigations
  • Published:
Human Genetics Aims and scope Submit manuscript

Summary

Hunter syndrome is a human X-linked disorder caused by deficiency of the lysosomal exohydrolase iduronate-2-sulphatase (IDS). The consequent accumulation of the mucopolysaccharides dermatan sulphate and heparan sulphate, in the brain and other tissues, often results in death before adulthood. There is, however, a broad spectrum of severity that has been attributed to different mutations of the Hunter syndrome gene. We have used an IDS cDNA clone to localise the IDS gene to Xq28, distal to the fragile X mutation (FRAXA). One-third of Hunter syndrome patients had various deletions or rearrangements of their IDS gene, proving that different mutations are common in this condition. Deletions of the IDS gene can include a conserved locus that is tightly linked to FRAXA, suggesting that deletion of nearby genes may contribute to the variable clinical severity noted in Hunter syndrome. The cDNA clone was also shown to span the X chromosome breakpoint in a female Hunter syndrome patient with an X;autosome translocation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bielicki J, Freeman C, Clements PR, Hopwood JJ (1990) Human liver iduronate-2-sulphatase: purification, characterization and catalytic properties. Biochem J 271:75–86

    Google Scholar 

  • Hopwood JJ (1982) α-l-Iduronidase, β-d-glucuronidase and 2-sulfo-l-iduronate-2-sulphatase preparation and characterization of radioactive substrates from heparin. Carbohydr Res 69:203–216

    Google Scholar 

  • Hopwood JJ (1989) Enzymes that degrade heparin and heparan sulphate. In: Lane D, Lindahl U (eds) Heparin: clinical and biological properties, clinical applications. Arnold, London, pp 191–288

    Google Scholar 

  • Hopwood JJ, Morris CP (1990) The mucopolysaccharidoses: diagnosis, molecular genetics and treatment. Mol Biol Med 7:381–404

    Google Scholar 

  • Hopwood JJ, Muller V, Harrison JR, Carey WF, Elliott H, Robertson EF, Pollard AC (1982) Enzymatic diagnosis of the mucopolysaccharidoses: experience of 96 cases diagnosed in a 5-year period. Med J Aust 1:257–260

    Google Scholar 

  • Lim TW, Leder IG, Bach G, Neufeld EF (1974) An assay for iduronate sulfatase (Hunter corrective factor). Carbohydr Res 37:103–109

    Google Scholar 

  • Mandel JL, Willard HF, Nussbaum RL, Romeo G, Puck JM, Davies KE (1989) Report of the committee on genetic constitution of the X chromosome. (10th International Workshop on Human Gene Mapping) Cytogenet Cell Genet 51:384–437

    Google Scholar 

  • Mossman J, Blunt S, Stephens R, Jones EE, Pembrey M (1983) Hunter disease in a girl: association with X∶5 chromosomal translocation disrupting the Hunter gene. Arch Dis Child 58:911–915

    Google Scholar 

  • Nelson PV, Carey WF, Morris CP, Pollard AC (1989) Cystic fibrosis: prenatal diagnosis and carrier detection by DNA analysis. Med J Aust 151:126–131

    Google Scholar 

  • Neufeld EF, Muenzer J (1989) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 1565–1588

    Google Scholar 

  • Roberts SH, Upadhyaya M, Sarfarazi M, Harper PS (1989) Further evidence localising the gene for Hunter's syndrome to the distal region of the X chromosome long arm. J Med Genet 26:309–313

    Google Scholar 

  • Robertson DA, Callen DF, Baker EG, Morris CP, Hopwood JJ (1988) Chromosomal localization of the gene for human glucosamine-6-sulphatase to 12q14. Hum Genet 79:175–178

    Google Scholar 

  • Simmers RN, Smith J, Shannon MF, Wong G, Lopz AF, Baker E, Sutherland GR, Vadas MA (1988) Localization of the human G-CSF gene to region of breakpoint in the translocation typical of acute promyelocytic leukaemia. Hum Genet 78:134–136

    Google Scholar 

  • Sutherland GR, Hecht F (1985) Fragile sites on human chromosomes. Oxford University Press, New York

    Google Scholar 

  • Suthers GK, Callen DF, Hyland VJ, Kozman HM, Baker E, Eyre H, Harper PS, Roberts SH, Hors-Cayla MC, Davies KE, Bell MV, Sutherland GR (1989) A new DNA marker tightly linked to the fragile X locus (FRAXA). Science 246:1298–300

    MathSciNet  MATH  Google Scholar 

  • Wilson PJ, Morris CP, Anson DS, Occhiodoro T, Bielicki J, Clements PR, Hopwood JJ (1990) Hunter syndrome: isolation of an iduronate-2-sulphatase cDNA clone and analysis of patient DNA. Proc Natl Acad Sci USA 87:8531–8535

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilson, P.J., Suthers, G.K., Callen, D.F. et al. Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome. Hum Genet 86, 505–508 (1991). https://doi.org/10.1007/BF00194643

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00194643

Keywords

Navigation